Pot Inc. is waiting to cash in on Trump’s marijuana reclassification — but the DOJ is still dragging its feet

The US government is finally inching closer to loosening its strict regulations over marijuana, but whether that will be enough to take pot mainstream like booze and tobacco remains a hazy question. 

The Justice Department is putting final touches on President Trump’s Dec. 18 executive order moving weed out of the “Schedule 1” classification for hard drugs like heroin — and into something far less draconian and hopefully more bankable, top pot executives and investors tell The Post.

To be precise, US Attorney General Pam Bondi is poised to shift weed into the semi-legal classification of a “Schedule 3” drug alongside medications like codeine-laced Tylenol that can be prescribed by a doctor.

That’s when some investors are hoping the financing spigots for Pot Inc. will start to open.

What’s holding it up? Weed execs chalk it up to the fact that the White House and the DOJ have a lot on their plates. Their sources say the administration is nearly ready to publish a new final rule in the Federal Register that officially moves marijuana onto Schedule 3.

A person with firsthand knowledge of the DOJ’s handling of the matter says there is no deadline for Bondi’s action (he denies delays because of war or Epstein). Rather, the process is a complicated one and attorneys on the case are methodically working on the matter.